Ubiquitin ligases: Cell-cycle control and cancer

Keiichi I. Nakayama, Keiko Nakayama

Research output: Contribution to journalReview article

976 Citations (Scopus)

Abstract

A driving force of the cell cycle is the activation of cyclin-dependent kinases (CDKs), the activities of which are controlled by the ubiquitin-mediated proteolysis of key regulators such as cyclins and CDK inhibitors. Two ubiquitin ligases, the SKP1-CUL1-F-box-protein (SCF) complex and the anaphase-promoting complex/cyclosome (APC/C), are responsible for the specific ubiquitylation of many of these regulators. Deregulation of the proteolytic system might result in uncontrolled proliferation, genomic instability and cancer. Cumulative clinical evidence shows alterations in the ubiquitylation of cell-cycle regulators in the aetiology of many human malignancies. A better understanding of the ubiquitylation machinery will provide new insights into the regulatory biology of cell-cycle transitions and the development of anti-cancer drugs.

Original languageEnglish
Pages (from-to)369-381
Number of pages13
JournalNature Reviews Cancer
Volume6
Issue number5
DOIs
Publication statusPublished - 2006 May 1

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Ubiquitin ligases: Cell-cycle control and cancer'. Together they form a unique fingerprint.

  • Cite this